 Citigroup Inc. increased its position in Eidos Therapeutics Inc NASDAQ:EIDX by 766.9 during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission SEC. The firm owned 15,690 shares of the companys stock after acquiring an additional 13,880 shares during the period. Citigroup Inc.s holdings in ... 